الانتقال إلى عملات مشفرة أخرى
ASTCAstrotech Corporation
Astrotech Corporation
ASTCWhat Is Astrotech Corporation (ASTC)?
TL;DR
Astrotech Corporation (ASTC) is a highly speculative micro-cap (~$4.5M market cap) pivoting from space services to miniaturized mass spectrometry and security detection technology, characterized by extreme volatility, delisting risk, and binary event-driven price swings that attract special-situations traders rather than institutional investors.
Astrotech Corporation (NASDAQ: ASTC) is a science and technology development company that invents, acquires, and commercializes technological innovations — a business identity that has evolved dramatically from its origins as a space-payload services provider into a focused micro-analytical instrumentation firm.
As Benzinga's editorial team describes it, the company "invents, acquires and commercializes technological innovations sourced from internal research, universities, laboratories and research institutions." That mission today centers almost entirely on a proprietary miniaturized mass spectrometry platform with applications in security screening, chemical detection, and breath analysis.
From SPACEHAB to Mass Spectrometry: A Pivotal Rebrand
According to Seeking Alpha's company profile, Astrotech "was formerly known as SPACEHAB, Inc. and changed its name to Astrotech Corporation in 2009," marking a structural break from its legacy space-services identity.
That pivot planted the seeds of the company it is today: according to Seeking Alpha, Astrotech now "operates as a mass spectrometry company" that "owns and licenses the intellectual property related to the Astrotech Mass Spectrometer Technology, a platform mass spectrometry technology."
The transition reflects a deliberate repositioning toward government, defense, and industrial end-markets where portable chemical detection has genuine commercial utility — provided the company can survive long enough to reach those customers at scale.
Core Product Portfolio
Astrotech's technology suite, as detailed by Seeking Alpha, comprises three primary instruments:
| Product | Application |
|---|---|
| TRACER 1000 | Mass spectrometer-based explosive trace detector for airports, cargo facilities, and border security |
| BreathTest-1000 | Breath analysis platform targeting volatile organic compound detection |
| Pro-Control 1000-D2 | General-purpose mass spectrometer platform |
The TRACER 1000 represents the company's most commercially mature asset. As of May 2026, Astrotech's 1st Detect subsidiary secured ECAC/EU G1 certification for the TRACER 1000, according to Timothy Sykes News, positioning it to pursue aviation-security contracts across EU and ECAC-linked markets — a meaningful credentialing milestone for a company of this size.
Traders monitoring drone imaging and defense tech themes may find parallels in how ASTC's security detection technology fits into the broader government-procurement pipeline, even if the company's scale remains orders of magnitude smaller than sector peers.
Scale, Financials, and Structural Risk
As of May 2026, CompaniesMarketCap data places Astrotech's market capitalization at approximately $4.53–$4.59 million, ranking it 10,591st among all globally ranked companies by market capitalization. That positions ASTC firmly in nano-cap territory, where institutional coverage is minimal and price discovery is driven almost entirely by retail and event-driven participants.
The financial reality underlying that market cap is stark. According to Institutional Equity Research citing Astrotech's latest Form 10-Q, the company is "a microcap mass spectrometry instrument company" with an annual product revenue run rate of less than $1.5 million.
For Q3 of fiscal year 2026, consolidated revenue was just $343,000 — down over 35% year-over-year — bringing the nine-month FY2026 revenue total to $787,000 with a gross profit of $262,000 over that same period.
More critically, the same institutional research estimates a monthly cash burn rate of approximately $1.18 million and an operational runway of roughly 5.5 months, implying a potential cash depletion around September 2026 absent new financing:
> "With a critical operational cash burn rate of about $1.18 million every single month, the company is on track to run out of cash around September 2026 without new financing." > — Lead Analyst, Institutional Equity Research, *Astrotech Corporation Institutional Equity Research and Market Commentary*, May 2026
To maintain its Nasdaq listing over the years, Institutional Equity Research notes that Astrotech has executed reverse stock splits of 1-for-30, 1-for-5, and 1-for-10 — a cumulative reverse split ratio of 1-for-1,500 — a statistic that encapsulates the persistent pressure on the company's capital structure.
Seeking Alpha data indicates a one-year price performance of approximately −35.10% through 2025–2026, consistent with ongoing financing needs and the episodic, contract-dependent nature of the business.
The Speculative Dimension: Lunar Initiative
In May 2026, Astrotech's Board of Directors approved a strategic lunar resource and infrastructure initiative targeting future Moon-based industrial activity, according to StockTitan. The announcement triggered an intraday surge of approximately 80.87% in ASTC shares, per Timothy Sykes News.
However, Institutional Equity Research analysts were direct in their assessment: the lunar segment "currently holds absolutely zero physical assets, zero infrastructure, and zero contracted space-flight berths — it is 100% just a concept at this stage."
For traders evaluating ASTC, distinguishing between its tangible mass spectrometry IP and its conceptual space ambitions is essential context before any position decision. For broader perspective on micro-cap technology names navigating binary catalysts and capital cycles, the 2026 Stocks Market Outlook provides useful sector-level framing.
Last updated: 2026-06-20
الرؤى الرئيسية
- ASTC's core value proposition is entirely contingent on commercializing its proprietary miniaturized mass spectrometry technology — without a scaled revenue contract, the IP premium cannot offset the structural capital and compliance risks dragging the stock.
- The Smiths Detection partnership represents the single most important external validation signal for ASTC: it provides a credible route to institutional security markets that the company could never access alone, making partnership news the highest-impact catalyst to monitor.
- Nasdaq listing compliance is an ongoing existential variable — ASTC has previously faced delisting proceedings triggered by earnings misses, meaning every quarterly filing is a potential binary event that can reprice the stock by multiples in either direction.
- CEO insider purchasing of 1.8 million shares is a meaningful alignment signal for a company this size, where management's personal capital at risk is a disproportionately large fraction of total market cap — a factor that distinguishes ASTC from most micro-caps where insiders are net sellers.
- At a ~$4.5M market cap ranked 10,591st globally, ASTC occupies the extreme tail of tradeable equities where any single contract win, regulatory approval, or institutional discovery event can produce percentage gains that are structurally impossible for large-caps — the asymmetry cuts both ways.
النقاط الرئيسية
- •ASTC performance is closely tied to quarterly earnings results and forward guidance.
- •Sector rotation and institutional fund flows can drive significant price moves.
- •Macro sensitivity remains high — Fed policy, inflation data, and yield curves all influence valuation.
السعر وبنية السوق
حالة نظام التداول
Why Trade ASTC? Catalysts, Risks & the Special-Situations Case
Astrotech Corporation represents one of the purest expressions of a special-situations micro-cap trade available in public equity markets: a binary outcome story where the upside case and the downside case are both credible, both extreme, and both contingent on a small number of observable catalysts.
As of June 2026, with a market capitalization of approximately $4.5 million according to CompaniesMarketCap citing Nasdaq data, the stock is priced closer to liquidation value than to any reasonable commercial success scenario — which is precisely what makes it interesting to speculative traders and dangerous to undisciplined ones.
The Bull Case: IP Undervaluation and the Smiths Detection Catalyst
The core bull thesis for ASTC rests on a single high-conviction premise: miniaturized mass spectrometry, if it achieves scaled commercial adoption, is worth multiples of the current market capitalization.
The intellectual property underpinning the TRACER 1000 and associated platforms represents years of development cost that would be expensive and time-consuming for a competitor to replicate from scratch.
According to Seeking Alpha analysis, independent equity analysts have framed ASTC as "significantly undervalued" relative to its technology and IP, with the constraint being execution and capital structure rather than the underlying technology's commercial merit.
The most material near-term catalyst amplifying that bull case is the Smiths Detection partnership. Smiths Detection is an established global provider of threat detection solutions with deep relationships across government procurement agencies, airport authorities, and border security organizations — precisely the end-markets ASTC's TRACER 1000 targets.
For a company with a sub-$5 million market cap, access to an established partner's distribution network and procurement relationships removes the single hardest commercial challenge: getting from a working product to a signed government contract.
Analyst commentary has characterized this partnership as marking "a new era for Astrotech shares," reflecting the degree to which it de-risks the go-to-market execution problem.
Traders following the broader defense tech breakout theme will recognize that government security procurement tends to be sticky and high-margin once a vendor achieves qualification — the ECAC/EU G1 certification secured by 1st Detect in May 2026 being a direct step toward that status.
CEO insider buying — approximately 1.8 million shares purchased with personal capital — provides a secondary contrarian bullish signal. Management that converts personal wealth into equity at these prices is communicating conviction that the market's assessment is too pessimistic. That signal carries genuine information value, even if it is not dispositive.
The Bear Case: Delisting, Dilution, and Execution Failure
The bear case is structurally simpler and in some respects more probable over any given short-term window. Three risks dominate:
| Risk Factor | Mechanism | Trigger |
|---|---|---|
| Nasdaq delisting | Compliance deficiency → forced selling → loss of capital market access | Poor earnings, bid price breach, equity standard failure |
| Dilution | Equity issuance to fund operations → ownership erosion per share | Ongoing; each capital raise reduces existing holders' percentage |
| Execution failure | Partnership generates no contracts → revenue remains near zero | Commercial cycle slower than cash burn rate |
Delisting risk is the most acute structural threat. ASTC has previously received Nasdaq deficiency notices following poor earnings, and each quarterly reporting cycle carries binary event risk.
A compliance failure does not merely reduce the stock's value — it can effectively terminate the company's access to the public capital markets it depends on for survival, triggering a cascade from forced selling to funding collapse.
According to Seeking Alpha's overview, ASTC's one-year performance through mid-2026 stands at approximately −35%, reflecting a market that prices this risk continuously.
Dilution is persistent rather than episodic. At this revenue stage, equity issuance is the primary funding mechanism, meaning the bull thesis must account for a denominator that grows with every financing round. Even if the Smiths Detection partnership ultimately generates contracts, existing shareholders may own a materially smaller percentage of the company by the time revenue materializes.
Insider conviction, while a genuine positive signal, does not eliminate these risks. Management confidence and poor earnings outcomes have previously coexisted — the CEO's personal capital is at risk alongside common shareholders, but his time horizon and risk tolerance may differ significantly from a leveraged trader's.
Conditions That Define Which Scenario Dominates
The investment thesis resolves around observable milestones rather than opinion. The bull scenario becomes dominant when: commercial contracts referencing the Smiths Detection channel are announced, cash runway extends through at least two additional reporting cycles without a compliance breach, and revenue growth creates a credible path to Nasdaq-compliant financials.
The bear scenario dominates when: a deficiency notice arrives without a rapid cure plan, a dilutive capital raise at a deep discount closes, or the Smiths Detection partnership produces no contract announcements over an extended period.
For leveraged traders on CoinUnited.io, where ASTC trades 24/7 with no session gaps, the key advantage is the ability to react immediately to any of these catalysts — partnership announcements, SEC filings disclosing share issuances, or Nasdaq compliance communications — without waiting for market open.
The risk is symmetric: high leverage against a stock with this volatility profile requires precise position sizing and pre-defined exit levels. This is not a position to hold passively; it is a thesis to monitor actively.
ASTC vs. the Detection & Spectrometry Landscape: Competitive Positioning
Astrotech Corporation competes in a detection and analytical instrumentation market dominated by companies with resources and scale that dwarf its own — understanding where ASTC sits in that hierarchy is essential for traders evaluating whether the company's technology edge is commercially defensible or structurally vulnerable.
The Benchmark Competitive Landscape
According to Straits Research's *Mass Spectrometry Market Size, Share & Growth Analysis 2034* (February 2025), the global mass spectrometry market was estimated at USD 5.26 billion in 2024 and is projected to reach USD 10.24 billion by 2034, reflecting a 6.9% CAGR over that period.
The same research characterizes this market as "moderately consolidated," with dominance held by established names including Thermo Fisher Scientific, Agilent Technologies, Waters Corporation, Bruker Corporation, and Shimadzu Corporation.
These are billion-dollar enterprises with global sales forces, entrenched customer relationships, proprietary manufacturing infrastructure, and decades of installed-base loyalty — the structural advantages that ASTC, at a market capitalization of roughly $4.5 million as of May 2026, categorically cannot replicate.
Bruker Corporation (BRKR) and Waters Corporation (WAT) are perhaps the most instructive comparisons: both serve the analytical instrumentation segment with laboratory-grade precision, commanding billion-dollar valuations that dwarf ASTC by several orders of magnitude.
ASTC's differentiation claim is not laboratory fidelity but field-portable miniaturization — targeting security screening, border control, and on-site environmental testing rather than pharmaceutical or research-laboratory workflows.
These are genuinely distinct use-case segments, which means the competitive comparison is not purely head-to-head, but ASTC still faces well-resourced incumbents pursuing the same portable-detection opportunity.
The Smiths Detection Duality
Perhaps no relationship better illustrates the complexity of ASTC's competitive position than its association with Smiths Detection, the security-screening division of Smiths Group plc and one of the dominant players in airport explosive and narcotics detection globally.
Smiths Detection is simultaneously a potential channel partner and a capable competitor — a dynamic common among micro-cap technology developers that depend on larger players for market access while those same players could theoretically develop or acquire competing capabilities.
For ASTC, navigating this duality is a central strategic challenge that has no clean resolution at the company's current scale.
The narcotics scanner market — a primary application arena where Smiths Detection holds significant market share — was valued at USD 6.23 billion in 2025 and is projected to reach USD 13.63 billion by 2035 at an 8.13% CAGR, according to SNS Insider's *Narcotics Scanner Market Size, Share & Growth Report 2035* (November 2025).
That growth trajectory is driven by increasing government demand for real-time, non-intrusive screening at airports, borders, and critical infrastructure — precisely the deployment context ASTC's TRACER 1000 targets.
The Miniaturization Moat: Real but Fragile
ASTC's competitive moat, to the extent one exists, rests almost entirely on proprietary miniaturization intellectual property rather than manufacturing scale, brand equity, or multi-year customer contracts.
As Straits Research analysts note, there is growing demand for "compact, portable mass spectrometers" enabled by advances in microfabrication and ionization technologies — a trend that validates ASTC's strategic bet but simultaneously signals that larger, better-capitalized players are actively investing in the same direction.
Market Data Forecast's *Water Testing & Analysis Market Size & Share Report, 2034* (September 2025) reinforces the structural demand shift, noting that "miniaturized spectrometers allow for the on-site detection of contaminants, supporting faster decision-making compared to centralized laboratory testing."
The environmental monitoring segment alone — spanning water testing and microplastic detection — represents a significant long-run opportunity; Fortune Business Insights projects the microplastic detection market to reach USD 9.11 billion by 2034 at a 6.49% CAGR, driven partly by spectrometric detection systems.
The risk is straightforward: a moat built on patent defensibility is only as strong as the patents themselves and the legal resources available to enforce them — a meaningful constraint for a company of ASTC's size.
Micro-Cap Asymmetry and Thematic Tailwinds
At a market capitalization in the low single-digit millions, ASTC exhibits a structural asymmetry that distinguishes it sharply from its larger peers.
A contract win, regulatory certification, or partnership expansion that would move a mid-cap instrumentation company's stock by low single-digit percentages can produce double- or triple-digit percentage moves for ASTC — because the news represents a proportionally enormous change in the company's commercial trajectory relative to its current valuation.
Beyond company-specific catalysts, the broader drone imaging and defense tech thematic provides a sectoral tailwind that can lift sentiment across small detection-technology names simultaneously.
When government procurement budgets for security screening, border technology, and field-deployable detection expand — as they have amid ongoing geopolitical pressures — capital flows into the theme can benefit micro-cap names like ASTC even in the absence of company-specific news, simply through sector-level re-rating.
| Competitor / Peer | Market Position | ASTC Differentiation |
|---|---|---|
| Thermo Fisher, Agilent, Waters, Bruker | Billion-dollar lab-grade MS incumbents | Portable/field-deployable vs. laboratory |
| Smiths Detection | Airport security screening leader | Potential partner and/or channel competitor |
| Micro-cap detection peers | Comparable scale, fragmented | ASTC's miniaturization IP as primary moat |
For leveraged traders on CoinUnited.io, ASTC's competitive positioning means that monitoring partnership announcements, regulatory certifications, and defense-procurement thematic flows is at least as important as tracking traditional valuation metrics — because at this market cap, narrative and catalyst drive price action far more than earnings multiples.
هل أنت مستعد للتداول ASTC؟
حتى 2000x رافعة مالية · صفر رسوم · تداول على مدار الساعة
Trading ASTC CFDs on CoinUnited.io: Strategy, Leverage & Risk Management
Trading Astrotech Corporation (ASTC) CFDs on CoinUnited.io demands a fundamentally different risk framework than trading large-cap or even mid-cap equity CFDs — the underlying is a stock with a market capitalization of approximately $4.53 million as of May 2026 (according to CompaniesMarketCap citing Nasdaq data), a one-year price performance of −35.10% (Seeking Alpha, 2025–2026), and average
daily share volume that frequently falls below 50,000 shares per session (Seeking Alpha equity notes, 2025). These are not the characteristics of a name where maximum leverage is a sensible starting point. They are the characteristics of a name where capital preservation is an active job.
Understanding ASTC's Leverage Ceiling — and Why You Should Ignore It
CoinUnited.io makes available up to 1000x leverage on ASTC CFDs with zero trading fees. That ceiling exists as a structural tool for precision-sized exposure, not as a target allocation for a name this volatile.
A stock capable of moving 30–50% in a single session — which Investopedia's *Trading Microcap Stocks* notes is "not unusual" for thinly traded micro-caps after earnings or regulatory news — can obliterate a highly leveraged CFD position before any stop-loss order is actionable.
As Andrew Bloomenthal, Senior Financial Writer at Investopedia, stated in the platform's updated CFD guide (2025-03):
> "Leverage magnifies the impact of every trading decision; in CFDs on volatile underlyings, a modest price move can wipe out most or all of a retail trader's equity."
For ASTC specifically, experienced traders treat even 5–20x leverage as meaningful amplification. At 20x, a 5% adverse move against a position eliminates the entire margin allocated to that trade. At 100x, a 1% adverse gap — well within ASTC's intraday volatility range — has the same effect. Position sizing discipline is therefore not optional; it is the core risk control mechanism.
According to Investopedia's position sizing guidance (2024-12) and tastytrade's *Managing Risk in Small-Cap Trading* (2024-12), active traders commonly cap a single micro-cap position at 1–2% of total trading equity, with aggregate micro-cap exposure limited to no more than 5–10% of the portfolio.
The Two Binary Catalysts That Define ASTC Price Action
For an event-driven micro-cap like ASTC, two calendar events carry disproportionate weight: quarterly earnings releases and Nasdaq compliance communications.
Empirical studies summarized by Investopedia (*Earnings Announcements and Stock Price Volatility*, 2025-02) show that small and micro-cap stocks experience average absolute price gaps of 8–15% on the day after earnings — and for thinly traded names, moves at the extreme end of that distribution or beyond are common.
Nathan Ronen, CMT, writing for Investopedia's *Event-Driven Trading: Strategies and Risks* (2024-12), is direct on the necessary response:
> "Event-driven trading around earnings and regulatory announcements can be attractive in small and micro-cap stocks, but gap risk is substantial and must be controlled through conservative position sizing and predefined exits."
CoinUnited.io's 24/7 CFD access provides a structural advantage here that holders of the Nasdaq-listed underlying do not enjoy.
When ASTC reports earnings after the 4:00pm ET close, or when a Nasdaq compliance notice appears in an SEC filing outside regular trading hours, CoinUnited traders can react immediately — not at the 9:30am ET NYSE/Nasdaq cash session open the following morning, where the full gap risk would otherwise be borne by any position holder unable to act.
As Investopedia's *Nasdaq Listing Requirements Explained* (2024-12) notes, micro-cap issuers that periodically approach minimum bid and market-value thresholds can themselves trigger sharp, gap-driven moves when compliance notices or cure announcements are published — events that arrive on no predictable schedule and frequently outside exchange hours.
Similarly, weekend positioning allows traders to respond to M&A speculation, partnership announcements, or regulatory filings that surface on Saturdays or Sundays, capturing movement ahead of Monday's cash open rather than absorbing a gap from it.
Traders tracking the broader energy, pharma, and tech acquisition wave will recognize that surprise deal announcements — the kind most likely to move a micro-cap decisively — rarely respect market hours.
Practical Position Structuring for ASTC
Given ASTC's binary risk profile, the asymmetric position structure used by experienced traders applies directly: small initial size with pre-planned add points on confirmation, rather than full-size entries ahead of unknown outcomes.
The 1000x leverage ceiling is most intelligently used to take a small, precisely-sized exposure — not to amplify a large notional position into a name where a single adverse headline can move the stock 30%+.
A worked example illustrates the mechanics:
| Scenario | Account Equity | Position Size (1% of equity) | Leverage Applied | Notional Controlled | Adverse Move to Wipe Position |
|---|---|---|---|---|---|
| Conservative | $10,000 | $100 | 10x | $1,000 | ~10% move against |
| Moderate | $10,000 | $100 | 50x | $5,000 | ~2% move against |
| Aggressive | $10,000 | $100 | 200x | $20,000 | ~0.5% move against |
For a stock with intraday ranges that routinely exceed 5–10%, only the conservative scenario in the table above leaves meaningful room for a trade to develop before the position is at risk of liquidation.
On stop placement: tastytrade's *Volatility and Stop Placement* segment (2024-11) recommends stops of 8–15% below entry for volatile micro-caps — significantly wider than the 2–3% stops appropriate for large-cap names — to avoid being stopped out by normal intraday noise before the actual catalyst resolves.
Critically, these stops must be defined before entering the trade, not constructed reactively after a position begins moving against you. ASTC's thin underlying liquidity means that spread and slippage risk is elevated at all times and more pronounced around catalyst events, reinforcing the principle that ASTC positions are event-driven, time-limited trades — not passive holds.
Tom Sosnoff, Co-Founder of tastytrade, summarized the overriding principle in his *Leverage, Volatility and Position Sizing* segment (2024-11):
> "In high-volatility names, you manage risk with size first, not with prediction — keeping your notional exposure small relative to account size is critical when using leverage."
For ASTC CFD traders on CoinUnited.io, that principle is not a guideline. It is the foundation on which every other strategic decision rests.
ابدأ رحلتك في التداول
19,000+ أداة عبر 7 أسواق · ابدأ في 10 ثوانٍ
رمز
ASTC
الأسواق
Stocks
رمز منتج CU
ASTC
الوسوم
الأسئلة المتكررة
Astrotech Corporation has evolved from its space-services roots into a micro-analytical technology company, now focused primarily on mass spectrometry and detection platforms rather than aerospace operations. The company's current business centers on miniaturized scientific instrumentation with applications in security screening, chemical detection, and scientific analysis — a significant strategic pivot from its legacy space-services identity. While the 'Astro' branding and aerospace heritage remain part of the company's identity, the investment case today is almost entirely built around its micro-analytical IP and whether that technology can win commercial or government contracts. Independent analysts on platforms like Seeking Alpha have framed ASTC under themes like 'Miniaturization of Spectrometry,' underscoring that the core story is now instrumentation technology, not satellites or launch services. Traders approaching ASTC should understand they are effectively trading a speculative detection-technology micro-cap, not a space stock.
تنبيهات وإشارات مرجعية
تنويه هام حول المخاطر
جميع توقعات وأسعار Astrotech Corporation المعروضة على هذه المنصة هي لأغراض إعلامية وتعليمية بحتة. لا تُعتبر نصيحة مالية أو توصيات استثمارية أو إرشادات من أي نوع.
أسواق العملات الرقمية شديدة التقلب وغير قابلة للتنبؤ. الأداء السابق لا يدل بأي شكل من الأشكال على النتائج المستقبلية. التوقعات المعروضة مبنية على نماذج رياضية، وتحليل للبيانات التاريخية، ومؤشرات تقنية متعددة، ولكنها لا تستطيع احتساب الأحداث السوقية غير المتوقعة أو التغيرات التنظيمية أو أي عوامل خارجية أخرى.
يجب على المستخدمين إجراء أبحاثهم الخاصة واستشارة متخصصين ماليين مؤهلين قبل اتخاذ أي قرارات استثمارية. لا يتحمل منشئو ومشغلو هذه المنصة أي مسؤولية عن أي خسائر مالية أو أضرار أخرى قد تنتج عن الاعتماد على المعلومات المقدمة.
الاستثمار في العملات الرقمية ينطوي على مخاطر كبيرة، بما في ذلك احتمال فقدان كامل قيمة الاستثمار.
نظرة عامة على المنهجية
تستخدم توقعات أسعار Astrotech Corporation لدينا نهجًا متعدد العوامل يجمع بين:
- التحليل الفني (المتوسطات المتحركة، المؤشرات، أشكال الرسوم البيانية)
- نماذج التعلم الآلي (شبكات LSTM، نماذج الانحدار)
- المقاييس على السلسلة (حجم المعاملات، العناوين النشطة، تدفقات البورصات)
- تحليل المشاعر (وسائل التواصل الاجتماعي، الأخبار، سيكولوجية الجماهير)
- العوامل الكلية (التضخم، أسعار الفائدة، الارتباط بالأسواق التقليدية)
آخر مراجعة للمنهجية:
هل أنت مستعد لبدء تداول Astrotech Corporation؟
انضم إلى آلاف المتداولين وابدأ رحلتك في تداول Astrotech Corporation اليوم. احصل على وصول إلى أدوات تداول متقدمة ورسوم تنافسية.